SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-18-031406
Filing Date
2018-12-26
Accepted
2018-12-26 16:03:15
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 achv-s3.htm S-3 664008
2 EX-4.6 achv-ex46_127.htm EX-4.6 48695
3 EX-4.7 achv-ex47_128.htm EX-4.7 722012
4 EX-4.8 achv-ex48_126.htm EX-4.8 51878
5 EX-4.9 achv-ex49_125.htm EX-4.9 741559
6 EX-5.1 achv-ex51_46.htm EX-5.1 36290
7 EX-23.1 achv-ex231_62.htm EX-23.1 2711
8 GRAPHIC g11mq4ttlzyf000002.jpg GRAPHIC 4187
9 GRAPHIC gzy03bdxmzss000001.jpg GRAPHIC 7455
10 GRAPHIC g11mq4ttlzyf000001.jpg GRAPHIC 4187
  Complete submission text file 0001564590-18-031406.txt   2290627
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229019 | Film No.: 181252712
SIC: 2835 In Vitro & In Vivo Diagnostic Substances